Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: adverse effects.

Academic Article


  • The three approved nucleoside analogues are fairly well tolerated, and only a few patients have to discontinue therapy permanently. However, because clinical experience is limited, especially with ddI and ddC, delayed toxicities are likely to emerge over time. In addition, physicians should be vigilant for overlapping toxicities from combination therapy with these and other medications.
  • Published In

  • Hospital Practice  Journal
  • Keywords

  • Acquired Immunodeficiency Syndrome, Antiviral Agents, Didanosine, Drug Therapy, Combination, HIV Infections, HIV-1, Humans, Zalcitabine, Zidovudine
  • Author List

  • Saag MS
  • Start Page

  • 26
  • End Page

  • 36
  • Volume

  • 27 Suppl 2